查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942732

2026年全球数位疗法市场报告

Digital Therapeutics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，数位疗法市场呈指数级增长，预计将从2025年的109.3亿美元增长到2026年的140.2亿美元，复合年增长率达28.3%。这一增长归因于智慧型手机在医疗保健领域的渗透率不断提高、数位健康解决方案的接受度不断提高、远端医疗服务的扩展、数位疗法监管核准速度加快以及慢性病负担日益加重。

预计未来几年，数位疗法市场将呈指数级增长，到2030年市场规模将达到378.2亿美元，复合年增长率（CAGR）为28.1%。预测期内的成长要素包括：数位疗法报销支持力度的加大、对个人化数位医疗需求的不断增长、人工智慧驱动的治疗平台的扩展、医疗服务提供者与科技公司之间合作的加强，以及对预防性数位健康的日益重视。预测期内的关键趋势包括：基于软体的治疗解决方案的日益普及、可穿戴健康设备的日益整合、远端患者监护平台的广泛应用、循证数位医疗项目的扩展，以及对个性化治疗路径的日益关注。

慢性病发病率的不断上升预计将成为推动数位疗法市场扩张的主要因素。需要长期医疗照护的慢性病对患者的日常生活影响巨大。数位疗法作为一种以软体为基础的介入手段，提供实证治疗方案，能够增强慢性病管理，为患者提供更多治疗选择。值得注意的是，根据美国疾病管制与预防中心（CDC）截至2022年7月的数据，十分之六的美国成年人患有慢性病，十分之四的成年人患有两种或两种以上的慢性病，​​例如心臟病、糖尿病和慢性肺病。慢性病的高发生率显着推动了数位疗法市场的成长。

数位疗法市场的主要企业正致力于技术创新，例如处方笺数位行为疗法平台，以扩大治疗覆盖范围、增强病人参与并提供经临床检验的疗效。处方笺数位行为疗法平台是基于软体的干预措施，可透过智慧型手机或平板电脑提供。它们融合了循证要素，例如认知行为疗法 (CBT)、远端监测和互动式目标追踪，从而实现扩充性的无药物疾病管理和个性化患者支持。例如，2023 年 7 月，总部位于美国的处方笺数位疗法公司 Better Therapeutics 推出了 AspyreRx（原名 BT 001），这是一款专为 2 型糖尿病设计的数位疗法。该解决方案透过智慧型手机应用程式提供为期 90 天的自我管理计划，包括每週一次的 CBT 课程、个人化目标设定以及血糖值和生活方式指标的监测。临床研究已证实，该方案能够持续降低糖化血红蛋白 (HbA1c) 水平、改善体重并提高生活品质。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球数位疗法市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 生物技术、基因组学和精准医学
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 以软体为基础的治疗解决方案正日益普及
    • 穿戴式健康设备的日益普及
    • 远端患者监护平台的使用范围不断扩大
    • 扩大循证数位医疗项目
    • 越来越重视个人化治疗方案

第五章 终端用户产业市场分析

  • 医院
  • 医疗保健提供者
  • 数位健康公司
  • 病人
  • 保险公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球数位疗法市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球数位疗法市场规模、对比及成长率分析
  • 全球数位疗法市场表现：规模与成长，2020-2025年
  • 全球数位疗法市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 软体、装置
  • 按销售管道
  • 企业对企业 (B2B)、企业对消费者 (B2C)
  • 透过使用
  • 预防、治疗或护理相关的应用
  • 按类型细分：软体
  • 行动应用程式、基于网路的平台和数位治疗软体
  • 按类型细分：设备
  • 穿戴式装置、生物感测器、数位治疗设备

第十章 区域与国家分析

  • 全球数位疗法市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球数位疗法市场：国家/地区、绩效及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 数位疗法市场：竞争格局及市场占有率（2024年）
  • 数位疗法市场：公司估值矩阵
  • 数位疗法市场：公司概况
    • Omada Health Inc.
    • WellDoc Inc.
    • 2Morrow Inc.
    • Propeller Health
    • Pear Therapeutics

第37章：其他领先和创新企业

  • Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年数位疗法市场：提供新机会的国家
  • 2030年数位疗法市场：充满新机会的细分领域
  • 2030年数位疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MDTHE01_G26Q1

Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.

The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.

Tariffs are influencing the digital therapeutics market by increasing costs of imported wearable components, biosensors, electronic modules, and supporting hardware devices. Healthcare providers and technology firms in North America and Europe are most affected due to dependence on imported electronics, while Asia-Pacific faces cost pressure on device manufacturing. These tariffs are increasing development and deployment costs. However, they are also encouraging local device assembly, regional software innovation, and greater emphasis on scalable software-centric therapeutic solutions.

The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics market size has grown exponentially in recent years. It will grow from $10.93 billion in 2025 to $14.02 billion in 2026 at a compound annual growth rate (CAGR) of 28.3%. The growth in the historic period can be attributed to growing smartphone penetration in healthcare, increased acceptance of digital health solutions, expansion of telemedicine services, early regulatory approvals for digital therapeutics, rising chronic disease burden.

The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $37.82 billion in 2030 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to increasing reimbursement support for digital therapeutics, rising demand for personalized digital care, expansion of ai-driven treatment platforms, growing partnerships between healthcare providers and tech firms, increasing focus on preventive digital health. Major trends in the forecast period include increasing adoption of software-based therapeutic solutions, rising integration of wearable health devices, growing use of remote patient monitoring platforms, expansion of evidence-based digital care programs, enhanced focus on personalized treatment pathways.

The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.

Major companies operating in the digital therapeutics market are concentrating on technological advancements such as prescription-only digital behavioral therapy platforms to expand treatment access, strengthen patient engagement, and deliver clinically validated outcomes. A prescription-only digital behavioral therapy platform employs software-based interventions delivered through smartphones or tablets, incorporating evidence-based components such as cognitive behavioral therapy (CBT), remote monitoring, and interactive goal tracking, enabling scalable, drug-free disease management and personalized patient support. For example, in July 2023, Better Therapeutics, a U.S.-based prescription digital therapeutics company, introduced AspyreRx (formerly BT 001), a digital therapeutic designed for type 2 diabetes. The solution offers a 90-day self-guided program via a smartphone application, including weekly CBT sessions, individualized goal setting, and monitoring of blood glucose and lifestyle metrics, with clinical studies showing sustained reductions in HbA1c, weight improvements, and enhanced quality-of-life outcomes.

In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.

Major companies operating in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Xealth, CogniFit Ltd.

North America was the largest region in the digital therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Software; Devices
  • 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
  • 3) By Application: Preventive Applications; Treatment Or Care-Related Applications
  • Subsegments:
  • 1) By Software: Mobile Applications; Web-Based Platforms; Digital Therapeutics Software
  • 2) By Devices: Wearable Devices; Biosensors; Digital Therapeutic Devices
  • Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Propeller Health; Pear Therapeutics; Canary Health Inc.; Noom Health Inc.; Akili Interactive Labs; Better Therapeutics; Happify Health; Kaia Health; Medtronic plc; Teladoc Health Inc.; Fitbit Health Solutions; EMulate Therapeutics; BigHealth; DarioHealth; IQVIA; JOGO Health; SilverCloud Health; Biofourmis Inc.; Prosoma; Virta Health Corp.; One Drop Inc.; Lark Health; Xealth; CogniFit Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Digital Therapeutics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Digital Therapeutics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Digital Therapeutics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Digital Therapeutics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Software-Based Therapeutic Solutions
    • 4.2.2 Rising Integration Of Wearable Health Devices
    • 4.2.3 Growing Use Of Remote Patient Monitoring Platforms
    • 4.2.4 Expansion Of Evidence-Based Digital Care Programs
    • 4.2.5 Enhanced Focus On Personalized Treatment Pathways

5. Digital Therapeutics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Healthcare Providers
  • 5.3 Digital Health Companies
  • 5.4 Patients
  • 5.5 Insurance Providers

6. Digital Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Digital Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Digital Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Digital Therapeutics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Digital Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Digital Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Digital Therapeutics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Digital Therapeutics Market Segmentation

  • 9.1. Global Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Devices
  • 9.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Business-To-Business (B2B), Business-To-Consumers (B2C)
  • 9.3. Global Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Preventive Applications, Treatment Or Care-Related Applications
  • 9.4. Global Digital Therapeutics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mobile Applications, Web-Based Platforms, Digital Therapeutics Software
  • 9.5. Global Digital Therapeutics Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Wearable Devices, Biosensors, Digital Therapeutic Devices

10. Digital Therapeutics Market Regional And Country Analysis

  • 10.1. Global Digital Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Digital Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Digital Therapeutics Market

  • 11.1. Asia-Pacific Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Digital Therapeutics Market

  • 12.1. China Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Digital Therapeutics Market

  • 13.1. India Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Digital Therapeutics Market

  • 14.1. Japan Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Digital Therapeutics Market

  • 15.1. Australia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Digital Therapeutics Market

  • 16.1. Indonesia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Digital Therapeutics Market

  • 17.1. South Korea Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Digital Therapeutics Market

  • 18.1. Taiwan Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Digital Therapeutics Market

  • 19.1. South East Asia Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Digital Therapeutics Market

  • 20.1. Western Europe Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Digital Therapeutics Market

  • 21.1. UK Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Digital Therapeutics Market

  • 22.1. Germany Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Digital Therapeutics Market

  • 23.1. France Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Digital Therapeutics Market

  • 24.1. Italy Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Digital Therapeutics Market

  • 25.1. Spain Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Digital Therapeutics Market

  • 26.1. Eastern Europe Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Digital Therapeutics Market

  • 27.1. Russia Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Digital Therapeutics Market

  • 28.1. North America Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Digital Therapeutics Market

  • 29.1. USA Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Digital Therapeutics Market

  • 30.1. Canada Digital Therapeutics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Digital Therapeutics Market

  • 31.1. South America Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Digital Therapeutics Market

  • 32.1. Brazil Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Digital Therapeutics Market

  • 33.1. Middle East Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Digital Therapeutics Market

  • 34.1. Africa Digital Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Digital Therapeutics Market, Segmentation By Product, Segmentation By Sales Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Digital Therapeutics Market Regulatory and Investment Landscape

36. Digital Therapeutics Market Competitive Landscape And Company Profiles

  • 36.1. Digital Therapeutics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Digital Therapeutics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Digital Therapeutics Market Company Profiles
    • 36.3.1. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Propeller Health Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

37. Digital Therapeutics Market Other Major And Innovative Companies

  • Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health

38. Global Digital Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Digital Therapeutics Market

40. Digital Therapeutics Market High Potential Countries, Segments and Strategies

  • 40.1 Digital Therapeutics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Digital Therapeutics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Digital Therapeutics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer